Submitted by Anonymous (not verified) on 17 September 2025 - 14:12
Human medicines European public assessment report (EPAR): Cabometyx, cabozantinib, Date of authorisation: 09/09/2016, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Cabometyx, cabozantinib, Date of authorisation: 09/09/2016, Revision: 19, Status: Authorised